PPARG and metabolic dysfunction-associated steatotic liver disease: Studies about NAFLD have shown that PPARγ (peroxisome proliferator-activated receptor γ) participates or regulates the fat deposition in liver by affecting the biological processes of hepatic lipid metabolism, insulin resistance, gluconeogenesis, oxidative stress, and inflammation, which all contribute to fatty liver.